晚期胰腺癌化疗和靶向治疗进展  

Progress in the treatment of metastatic pancreatic cancer

作　　者：张飞[1] 李宇红[1] 

机构地区：[1]中山大学肿瘤防治中心内科华南肿瘤学国家重点实验室肿瘤医学协同创新中心,广州510060

出　　处：《中国医师杂志》2015年第12期1785-1789,共5页Journal of Chinese Physician

摘　　要：胰腺癌（PC）恶性程度高，预后极差。化疗和靶向治疗是晚期PC综合治疗的重要组成部分。近年来，晚期PC的药物研究十分活跃，笔者就新型细胞毒和靶向药物治疗进展作一综述。Pancreatic cancer （PC） is one of the deadliest solid malignancies. Although surgery re- mains the only curative treatment, more than 80% of patients suffer relapse after resection. More and more data evidence that PC is a systemic disease suggests systemic therapy plays crucial roles in the multidiscipli- nary treatment. Thus, new treatments are urgently needed for PC patients. Recently, a growing number of novel and promising drugs are being evaluated in preclinical and clinical settings. Herein, we reviewed the progress in the new cytotoxic and targeted therapy for metastatic PC.

关 键 词：胰腺肿瘤/治疗 药物疗法 综述 

分 类 号：R735.9[医药卫生—肿瘤]